Lalu, M M <br/><br/>
Matrix metalloproteinases contribute to endotoxin and interleukin-1beta induced vascular dysfunction.  [electronic resource] 

 -  British journal of pharmacology  Sep 2006 
 - 31-42 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-1188 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjp.0706823  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Aorta, Thoracic<br/>Blotting, Western<br/>Collagenases--metabolism<br/>Endotoxemia--enzymology<br/>Endotoxins--blood<br/>Gelatinases--metabolism<br/>In Vitro Techniques<br/>Interleukin-1--toxicity<br/>Male<br/>Matrix Metalloproteinases--metabolism<br/>Muscle Contraction--drug effects<br/>Muscle Proteins--metabolism<br/>Muscle Tonus--drug effects<br/>Muscle, Smooth, Vascular--drug effects<br/>Nitrates--blood<br/>Nitrites--blood<br/>Phenylephrine--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Tissue Inhibitor of Metalloproteinase-1--metabolism<br/>Tissue Inhibitor of Metalloproteinases--metabolism<br/>Vascular Diseases--chemically induced<br/>Vasoconstrictor Agents--pharmacology<br/>Tissue Inhibitor of Metalloproteinase-4